Company Profiles

driven by the PitchBook Platform

Alector

Description

Developer of antibody technology designed to treat neurodegenerative diseases. The company's antibody technology generates and validates antibody drugs with functional properties that engage disease altering targets and develops novel therapeutics for alzheimer disease and other neurodegenerative disorders, enabling physicians harness the immune system to fight dementia and neurodegeneration.

2013

Founded

PRIVATE

Status

11-50

Employees

Series D

Latest Deal Type

$29.5M

Latest Deal Amount

$77.5M

Total Amount Raised

Description

Developer of antibody technology designed to treat neurodegenerative diseases. The company's antibody technology generates and validates antibody drugs with functional properties that engage disease altering targets and develops novel therapeutics for alzheimer disease and other neurodegenerative disorders, enabling physicians harness the immune system to fight dementia and neurodegeneration.

Website:

www.alector.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Biotechnology

Primary Office

151 Oyster Point Boulevard Suite 300 South San Francisco, CA 94080United States +1 (415) 231-5660
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Alector's full profile, request a free trial.

    Alector Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Alector Investors (14)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    AbbVie VenturesCorporate Venture CapitalMinority000 0000000 0000
    Amgen VenturesCorporate Venture CapitalMinority000 0000000 0000
    California Institute for Quantitative BiosciencesAccelerator/Incubator000 0000000 0000
    GVCorporate Venture CapitalMinority000 0000000 0000
    Janssen PharmaceuticalsVC-Backed CompanyMinority000 0000000 0000
    AbbVie Ventures Corporate Venture Capital
    Amgen Ventures Corporate Venture Capital
    California Institute for Quantitative Biosciences Accelerator/Incubator
    GV Corporate Venture Capital
    Janssen Pharmaceuticals VC-Backed Company

    Alector Executive Team (7)

    NameTitleBoard
    Seat
    Contact
    Info
    Arnon Rosenthal Ph.DCo-Founder, Chief Executive Officer & Board Member
    David MaddenConsulting Chief Financial Officer
    Tillman Gerngross Ph.DChairman & Co-Founder
    Sabah Oney Ph.DVice President, Business Development & Operations
    Robert Paul Ph.DChief Medical Officer
    Arnon Rosenthal Ph.D Co-Founder, Chief Executive Officer & Board Member
    David Madden Consulting Chief Financial Officer
    Tillman Gerngross Ph.D Chairman & Co-Founder
    Sabah Oney Ph.D Vice President, Business Development & Operations
    Robert Paul Ph.D Chief Medical Officer

    Alector Board Members (10)

    NameRepresentingRoleSinceContact
    Info
    Arnon Rosenthal Ph.DAlectorCo-Founder, Chief Executive Officer & Board Member000 0000
    Carl Gordon Ph.DOrbiMedFounding Partner & Co-Head of Global Private Equity000 0000
    James SullivanAlectorBoard Member000 0000
    Janis Naeve Ph.DAmgen VenturesManaging Director000 0000
    Joshua ResnickAlectorBoard Member000 0000
    Arnon Rosenthal Ph.D Co-Founder, Chief Executive Officer & Board Member Alector
    Carl Gordon Ph.D Founding Partner & Co-Head of Global Private Equity OrbiMed
    James Sullivan Board Member Alector
    Janis Naeve Ph.D Managing Director Amgen Ventures
    Joshua Resnick Board Member Alector
    Request full access to PitchBook